Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07104825 · ClinicalTrials.gov registry record · NA
Autonomic Neural Blockade in Bariatric Surgery
A NA study, sponsored by Endeavor Health.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07104825 is a NA study that has not yet begun recruiting, run by Endeavor Health. The registered enrollment target is 200 participants.
The verdict
NCT07104825, a NA study, has not yet begun recruiting, sponsored by Endeavor Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate if autonomic nerve block (ANB- blocking pain and nausea signals) decreases pain and anti-nausea medication requirements as well as the experience of pain/nausea during the first 72 hours after sleeve gastrectomy or gastric bypass surgery. Participants will be randomly assigned either to the standard of care or the ANB group before surgery. As part of standard of care, in both groups, laparoscopic bariatric surgery will be initiated with local anesthetic injected into the abdominal wall. In the ANB group, participants will be given an additional injection of local anesthetic medication to block nerves on and around the stomach.
Interventions
- PROCEDURE Intraoperative autonomic neural blockade (ANB)
- PROCEDURE Laparoscopic Standard of Care Abdominal Wall Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07104825
The ClinicalTrials.gov registry entry for NCT07104825 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intraoperative autonomic neural blockade (ANB) is the first listed.
NCT07104825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07104825 about?
NCT07104825 is a clinical study titled "Autonomic Neural Blockade in Bariatric Surgery". The purpose of this research is to evaluate if autonomic nerve block (ANB- blocking pain and nausea signals) decreases pain and anti-nausea medication requirements as well as the experience of pain/nausea during the first 72 hours after sleeve gastrectomy or gastric bypass surgery. Participants will...
What is the current status of trial NCT07104825?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-03. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07104825?
The interventions under investigation include: Intraoperative autonomic neural blockade (ANB) (PROCEDURE), Laparoscopic Standard of Care Abdominal Wall Block (PROCEDURE).
Who is sponsoring clinical trial NCT07104825?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.